AngioVac在非细菌性血栓性心内膜炎中的应用：系统综述

数据集获取（Figshare）

• 源站标题：Introducing the use of AngioVac in nonbacterial thrombotic endocarditis: a systematic review
• DOI：10.6084/m9.figshare.28557765.v1
• 发布日期：2025-03-08
• 文件数：3 个
• 文件总体积：159.08 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Introducing_the_use_of_AngioVac_in_nonbacterial_thrombotic_endocarditis_a_systematic_review/28557765

命令行下载

curl -L -o "Supplementary Material 1.docx" "https://ndownloader.figshare.com/files/52865088"
curl -L -o "Supplementary Material 2.docx" "https://ndownloader.figshare.com/files/52865091"
curl -L -o "Supplementary Table 1.docx" "https://ndownloader.figshare.com/files/52865094"

文件清单

• Supplementary Material 1.docx（63.56 KB）
• Supplementary Material 2.docx（65.96 KB）
• Supplementary Table 1.docx（29.56 KB）

文件总体积 159.08 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Nonbacterial thrombotic endocarditis (NBTE) involves vegetations on heart valves without active bloodstream infection. The AngioVac device, a vacuum-based aspiration system commonly used for infective endocarditis, has potential in managing NBTE, particularly in patients unsuitable for surgery. This study systematically reviews the literature to evaluate AngioVac’s effectiveness in reducing vegetations in NBTE.
A systematic literature review was conducted using PubMed, Embase, Cochrane, and Web of Science databases through February 2024. Primary outcome was procedural success, defined as a ≥ 50% reduction in vegetation size on transesophageal echocardiogram. Secondary outcomes included in-hospital mortality, hospital stay length, and procedural complications.
Out of 38 identified articles, 4 case reports met inclusion criteria. Patients were male with a median age of 60 years, and NBTE was associated with conditions such as lung adenocarcinoma, end-stage renal disease, and antiphospholipid syndrome. The mitral valve was the most commonly affected site. AngioVac achieved 100% procedural success, with no complications or in-hospital mortality. The average hospital stay was 2 days. Follow-up revealed one patient alive at 2 months, one deceased at 3 months and no data for two patients.
AngioVac is a promising tool for safely reducing vegetations in NBTE, especially for high-risk surgical candidates.
The study design and protocol are registered with PROSPERO International Prospective Register of Systematic Reviews (registration number CRD42024505295).
Nonbacterial thrombotic endocarditis (NBTE) is a condition where clumps of tissue, called vegetations, form on heart valves without a bacterial infection. The AngioVac device, a tool that works like a vacuum to remove clots and tissue, is commonly used for heart infections and may help treat NBTE in patients who cannot have surgery. This study reviewed past cases to see how effective AngioVac is in removing these vegetations.
Several medical databases (PubMed, Embase, Cochrane, and Web of Science) were searched for studies published in February 2024. Cases were included where AngioVac was used on adults with NBTE,

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.28557765.v1（source: https://tandf.figshare.com/articles/dataset/Introducing_the_use_of_AngioVac_in_nonbacterial_thrombotic_endocarditis_a_systematic_review/28557765）。